Safety and Tolerability of Ezetimibe- Reply

Abstract

Thank you for providing us with the opportunity to respond to the letter by Heller that raises questions about the safety and tolerability of ezetimibe. We fail to understand Dr. Heller’s conclusions that the “Tolerability and Safety” section of our article is “radically different” from the CCOHTA newsletter (1).